○Into Ri¹, Masaki Matsuoka¹, Yoshio Kodera^2,3, Hirotaka Imai¹ (1. Sch. of Pharm. Sci., Kitasato Univ., 2. Sch. of Sci., Kitasato Univ., 3. Center for Disease Proteomics, Sch. of Sci., Kitasato Univ. )

○Takeshi Kumagai^1,2, Rina Hirota^1,2, Risa Ohara¹, Hirotaka Imani^1,2 (1. Sch. of Pharm. Sci., Kitasato Univ., 2. AMED-CREST)

○Tomoko Koumura^1,2, Misaki Nakasone^1,2, Hirotaka Imai^1,2 (1. Sch. of Pharm. Sci., Kitasato Univ., 2. AMED-CREST)

○Masumi Mito^1,2, Tomoko Koumura^1,2, Hirotaka Imai^1,2 (1. Sch.of Pharm.Sci.,Kitasato Univ., 2. AMED-CREST)

○Junya Tomita¹, Takayama Kazuo^1,2,3,4, Hori Mika⁵, Shiba Mariko⁵, Mizuguchi Hiroyuki^1,2,3,6,7 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. PRESTO, 5. NCVC, 6. MEI cent., Osaka Univ., 7. ORTI, Osaka Univ.)

○Kenichi Ishibashi¹, Erika Matsuda¹, Reina Abe¹, Takumi Kawamura¹, Kotaro Hama¹, Kazuaki Yokoyama¹, Gen-ichi Atsumi¹ (1. Faculty of Pharma-Science, Teikyo University)

○Fumiyoshi Higashitarumi¹, Toko Maehara¹, Ko Fujimori¹ (1. Osaka Univ. Pharm. Sci.)

○Tsubasa Ochiai¹, Yuka Sasaki¹, Chieko Yokoyama², Shuntaro Hara¹ (1. Grad. Sch. Pharm., Shawa Univ., 2. Kanagawa Inst. of Tech)

○TOKO Maehara¹, Ko Fujimori¹ (1. Osaka Univ. Pharm. Sci.)

○Miho Hashimoto¹, kimaru Okubo¹, Tomoaki Inazumi¹, Toshiko Sugimoto¹, Soken Tsuchiya¹, Yukihiko Sugimoto¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ.)